PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Perindopril arginine - Hypertension
PAD Profile : Perindopril arginine - Hypertension
Keywords :
ACE inhibitors, high blood pressure, raised blood pressure, hypertension, heart failure, stable coronary artery disease, low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value
Brand Names Include :
Coversyl Arginine
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Aliskiren
- Bendroflumethiazide
- Candesartan cilexetil
- Eprosartan
- Indapamide
- Irbesartan
- Losartan potassium
- Olmesartan medoxomil
- Valsartan
- Ramipril
- Amlodipine
- Lisinopril
- Bisoprolol fumarate
- Doxazosin mesilate
- Diltiazem hydrochloride
- Nifedipine
- Perindopril erbumine
- Telmisartan
- Lisinopril / Hydrochlorothiazide
- Moxonidine
- Irbesartan / Hydrochlorothiazide
- Valsartan with hydrochlorothiazide
- Co-tenidone (Atenolol/chlortalidone)
- Enalapril maleate
- Quinapril hydrochloride
- Nebivolol
- Metolazone
- Azilsartan medoxomil
- Captopril
- Lercanidipine hydrochloride
- Nicardipine hydrochloride
- Chlortalidone
- Spironolactone
- Atenolol
- Carvedilol
- Celiprolol hydrochloride
- Metoprolol tartrate
- Propranolol hydrochloride
- Prazosin hydrochloride
- Clonidine hydrochloride
- Hydralazine hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Patient resource
01 January 2021
Committee Recommendations
Date
Committee Name
Narrative
03 June 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
22 January 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network does not recommend the use of perindopril arginine
Perindopril arginine will be considered BLACK on the traffic light system and prescribers should:
- NOT initiate perindopril arginine in any new patients
AND
- Switch any patients taking perindopril arginine to perindopril erbumine in line with NHS England guidance.
Associated BNF Codes
02. Cardiovascular System
02.05.05. Renin-angiotensin system drugs